Evidence map›Paper›PMID 24474103›Full record

ReviewAnais brasileiros de dermatologia

Treatment of superficial mycoses: review. Part II.

Maria Fernanda Reis Gavazzoni Dias, Fred Bernardes-Filho, Maria Victória Pinto Quaresma-Santos, Adriana Gutstein da Fonseca Amorim, Regina Casz Schechtman, David Rubem Azulay

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Anais brasileiros de dermatologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 41 citations in OpenAlex.

  1. Miconazole induces aneuploidy-mediated tolerance inFrontiers in cellular and infection microbiology · 2024
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Activity of the aqueous extract of Schinus terebinthifolius Raddi on strains of the Candida genus.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2016
    Article
  7. Current medical mycology · 2015
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Maria Fernanda Reis Gavazzoni DiasProf. Rubem David Azulay Dermatology Institute, Santa Casa da Misericórdia do Rio de Janeiro, Rio de JaneiroRJ, Brazil, MD, PhD, Professor of the Post-Graduation program at Prof. Rubem David Azulay Dermatology Institute at Santa Casa da Misericórdia do Rio de Janeiro (IDPRDA - SCMRJ) - Rio de Janeiro (RJ), Brazil.
Fred Bernardes-FilhoProf. Rubem David Azulay Dermatology Institute, Santa Casa da Misericórdia do Rio de Janeiro, Rio de JaneiroRJ, Brazil, MD, Post-graduation in course at Prof. Rubem David Azulay Dermatology Institute at Santa Casa da Misericórdia do Rio de Janeiro (IDPRDA - SCMRJ) - Rio de Janeiro (RJ), Brazil.
Maria Victória Pinto Quaresma-SantosProf. Rubem David Azulay Dermatology Institute, Santa Casa da Misericórdia do Rio de Janeiro, Rio de JaneiroRJ, Brazil, MD, Post-graduation in course at Prof. Rubem David Azulay Dermatology Institute at Santa Casa da Misericórdia do Rio de Janeiro (IDPRDA - SCMRJ) - Rio de Janeiro (RJ), Brazil.
Adriana Gutstein da Fonseca AmorimMD, Dermatologist - Private practice - Rio de Janeiro (RJ), Brazil.
Regina Casz SchechtmanLondon University, MD, PhD in Dermatology at London University. Coordinator of the Dermatology post-graduation program and chief of the mycology sector at Prof. Rubem David Azulay Dermatology Institute at Santa Casa da Misericórdia do Rio de Janeiro (IDPRDA - SCMRJ) - Rio de Janeiro (RJ), Brazil.
David Rubem AzulayDermatology Service, Prof. Rubem David Azulay Dermatology Institute, Santa Casa da Misericórdia do Rio de Janeiro, Rio de JaneiroRJ, Brazil, MD, MSc, Chief of the Dermatology Service at Prof. Rubem David Azulay Dermatology Institute at Santa Casa da Misericórdia do Rio de Janeiro (IDPRDA -SCMRJ) - Rio de Janeiro (RJ), Brazil. Chair Professor of the Post-graduation Program at Rio de Janeiro Pontifical Catholic University (PUC-RJ). Professor at Souza Marques Foundation and Rio de Janeiro Federal University (UFRJ) - Rio de Janeiro (RJ), Brazil.
Santa Casa de Misericórdia de Passos · BRPontifícia Universidade Católica de São Paulo · BRUniversidade do Estado do Rio de Janeiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Superficial fungal infections of the hair, skin and nails are a major cause of morbidity in the world. Choosing the right treatment is not always simple because of the possibility of drug interactions and side effects. The first part of the article discusses the main treatments for superficial mycoses - keratophytoses, dermatophytosis, candidiasis, with a practical approach to the most commonly-used topical and systemic drugs , referring also to their dosage and duration of use. Promising new, antifungal therapeutic alternatives are also highlighted, as well as available options on the Brazilian and world markets.

Indexed as

Antifungal AgentsDermatomycosesDrug InteractionsHumansTime FactorsAntifungal Agents

Identifiers

PMID24474103
PMCPMC3900345
OpenAlexW2058838299

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.